Tiziana Life Sciences Ltd (TLSA) Financials
TLSA Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| March 31, 2026 | 11.5 million | 11.4 million |
| Dec. 31, 2025 | 11.5 million | 11.4 million |
| Sept. 30, 2025 | 16.6 million | 7.4 million |
| June 30, 2025 | 16.6 million | 7.4 million |
TLSA Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| March 31, 2026 | -6.0 million | ? |
| Dec. 31, 2025 | -6.0 million | ? |
| Sept. 30, 2025 | -6.8 million | ? |
| June 30, 2025 | -6.8 million | ? |
TLSA Net Income
No data available :(
TLSA Cash and Debt
Graph available only for paid members. Upgrade to see it.
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| March 31, 2026 | 4.0 million | - | - |
| Dec. 31, 2025 | 4.0 million | - | 456000 |
| Sept. 30, 2025 | 7.3 million | - | - |
| June 30, 2025 | 7.3 million | - | - |
TLSA Shares Outstanding
TLSA Expenses
Graph available only for paid members. Upgrade to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| March 31, 2026 | 15000 | 7.0 million | - | - |
| Dec. 31, 2025 | 15000 | 7.0 million | 5.1 million | - |
| Sept. 30, 2025 | 5999 | 3.2 million | - | - |
| June 30, 2025 | 5999 | 3.2 million | 5.6 million | - |
TLSA Cost of Revenue
Graph available only for paid members. Upgrade to see it.
| Date | Revenue | Cost of Revenue |
|---|---|---|
| March 31, 2026 | - | 146000 |
| Dec. 31, 2025 | - | 146000 |
| Sept. 30, 2025 | - | 88000 |
| June 30, 2025 | - | 88000 |
TLSA
Price: $1.11
52 week price:
Earnings Per Share: -0.19 USD
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Country: United Kingdom
Volume: 67400
Market Capitalization: 68.1 million